Tscan Therapeutics has current Price Action Indicator of 0.33. Price Action indicator evaluates an asset for a given trading period using the following formula: ((close - open) + (close - high) + (close - low)) / 2. This indicator is consistent with the interpretation of Japanese candlestick patterns.
On November 22 2024 Tscan Therapeutics was traded for 4.26 at the closing time. The top price for the day was 4.26 and the lowest listed price was 3.92 . There was no trading activity during the period 0.0. Lack of trading volume on November 22, 2024 did not result in any price rise and fall. The trading price change against the current closing price is 7.51% .
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
For every potential investor in Tscan, whether a beginner or expert, Tscan Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Tscan Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Tscan. Basic forecasting techniques help filter out the noise by identifying Tscan Therapeutics' price trends.
Tscan Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Tscan Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Tscan Therapeutics' current price.
Market strength indicators help investors to evaluate how Tscan Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Tscan Therapeutics shares will generate the highest return on investment. By undertsting and applying Tscan Therapeutics stock market strength indicators, traders can identify Tscan Therapeutics entry and exit signals to maximize returns.
The analysis of Tscan Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Tscan Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting tscan stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When running Tscan Therapeutics' price analysis, check to measure Tscan Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tscan Therapeutics is operating at the current time. Most of Tscan Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tscan Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tscan Therapeutics' price. Additionally, you may evaluate how the addition of Tscan Therapeutics to your portfolios can decrease your overall portfolio volatility.